Heyu Biological Technology Corporation
Heyu Biological Technology Corporation (HYBT) Stock Overview
Explore Heyu Biological Technology Corporation’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
361.4M
P/E Ratio
241.19
EPS (TTM)
N/A
ROE
0.02%
HYBT Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Heyu Biological Technology Corporation (HYBT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $2.86.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 241.19 and a market capitalization of 361.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.